John Bashford

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 340 citations · Full text

Medicine, Hematology, Oncology +15

Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer

Sandra C. Hayes, Sheree Rye, Tracey DiSipio et al. · Breast Cancer Research and Treatment · 2012 · 195 citations

Medicine, Health Promotion, Oncology +16

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

Harry Iland, Marnie Collins, Ken Bradstock et al. · The Lancet Haematology · 2015 · 170 citations

Medicine, Hematology, Oncology +10

Prevalence and Prognostic Significance of Secondary Lymphedema Following Breast Cancer

Tracey Di Sipio, Sheree Rye, J. Alejandro López et al. · Lymphatic Research and Biology · 2011 · 87 citations · Full text

Medicine, Oncology, Breast Oncology +15

Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials

Sandra C. Hayes, Megan L. Steele, Rosalind R. Spence et al. · Breast Cancer Research and Treatment · 2017 · 83 citations · Full text

Medicine, Oncology, Physical Medicine +13